Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 46,874 shares at $12.37 ($588K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market sale of $588k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.37 | 14,800 | $183K | 31.1% |
| 2 | $12.63 | 16,037 | $203K | 34.4% |
| 3 | $12.63 | 16,037 | $203K | 34.4% |
| Total | $12.55 avg | 46,874 | $588K | 100% |
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |
| ACRS | SELL | 2022-12-16 | $79K | — | Filing → |